Developer docs
API playgroundTry for free, no card

Search company profiles

CFC International

Full company profile

uuid02lmdfl

Namestring
CFC International
Legal namestring
Cardio Facio Cutaneous syndrome International
Websiteurl
cfcsyndrome.org
Company typeenum
Private
Founded yearint
1999
Descriptiontext

CFC International (legal name: Cardio Facio Cutaneous syndrome International) is a U.S.-based non-profit patient advocacy and research organization founded in 1999 and headquartered in Largo, Florida. It serves families and caregivers affected by Cardio-facio-cutaneous (CFC) syndrome — an ultra-rare genetic Ras/MAPK pathway disorder — connecting more than 1,200 families across North America, South America, Europe, Asia Pacific, the Middle East, and Asia. Its core programs include the Family Liaisons volunteer mentorship network, the Family Connect monthly newsletter, educational webinars, support groups, family medical conferences, patient emergency micro grants, and the annual Unstoppably Bold Day awareness event.

The organization's technology and research footprint centers on the CITIZEN Patient Registry, a centralized de-identified patient data platform built in partnership with CITIZEN Health that incorporates integrative AI tools to accelerate CFC syndrome research. It also operates the Lillian's Legacy Research Grant program — a named memorial fund that has disbursed over $250,000 in research funding, including a $50,000 award in 2025 to Brigham and Women's Hospital for seizure-mechanism research — and publishes a Research & Clinical Trials information hub, a Zotero-based research library, and an interactive CFC World Map showing the geographic distribution of registered families.

CFC International does not sell products or services. It is funded through donations, fundraising events (including an annual golf tournament and JustGiving-hosted peer-to-peer fundraisers), and grants, and it is governed by a volunteer Board of Directors led by CEO Tuesdi Dyer and President Alexis Nash. It maintains core memberships across the rare-disease advocacy ecosystem, including NORD, Global Genes, Genetic Alliance, the Rasopathies Network, and the Children's Tumor Foundation, and operates with a small staff of 1–10 employees supplemented by a country-level volunteer liaison network.

Short descriptiontext

CFC International is a U.S.-based nonprofit founded in 1999 that supports more than 1,200 families worldwide affected by Cardio-facio-cutaneous syndrome through advocacy, education, research grants, an AI-integrated patient registry, and a global volunteer liaison network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLargo, United States
HQ citystring
Largo
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare disease advocacy, patient registry services, genetic syndrome support, medical research funding, nonprofit patient advocacy
NAICS code1 code
  • Other Individual and Family Services624190
Product category
Rare Disease Patient Advocacy
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

CFC International is a nonprofit patient advocacy organization that supports individuals and families affected by Cardio-facio-cutaneous (CFC) syndrome, a rare genetic disorder caused by mutations in MAPK pathway genes. The organization funds research, connects families, advocates for treatments, and operates the CITIZEN Patient Registry, a natural history study that uses AI to de-identify participant data for research use.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

CFC International operates as a non-profit patient advocacy and research organization — not a software technology company — offering a portfolio of patient-facing programs and research support services. The core offering is a coordinated set of support, education, and research-enabling programs including Family Liaisons (parent mentor connections), the CITIZEN Patient Registry (a centralized, AI-integrated de-identified data registry), Lillian's Legacy Research Grant (a named grant funding CFC syndrome research), Research & Clinical Trials information hub, and a global CFC World Map. These programs are supplemented by family medical conferences, webinars, support groups, patient emergency micro grants, and an annual awareness event (Unstoppably Bold Day). There is no commercial software product, platform, or API offering.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

CFC International is a proud member of NORD, a federation of voluntary health organizations dedicated to helping people with rare orphan diseases. This membership provides access to resources, advocacy support, and collaboration opportunities within the rare disease community.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

CFC International is affiliated with Global Genes, a leading rare disease patient advocacy organization that connects over 500 global organizations under a unifying symbol of hope.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

CFC International is a member of Genetic Alliance, a world-leading nonprofit health advocacy organization that engages individuals, families, and communities to transform health. The network includes over 1,200 disease-specific advocacy organizations.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

CFC International collaborates with the Rasopathies Network, an organization connecting syndromes including CFC, Costello, Leopard/NSML, NF1, and Noonan that share the Ras/MAPK pathway. These syndromes affect approximately 1 in 1,000 individuals.

Strategic tierCoreTypeTechnology or Integration
Description

CFC International partnered with CITIZEN to develop a centralized patient registry with integrative AI tools that connects researchers, patients, and families to accelerate CFC syndrome research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Recipient of CFC International's $50,000 Lillian's Legacy Research Grant for Dr. Sattar Khoshkhoo's research on seizures in CFC syndrome.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a member organization, collaborating within the rare disease and Rasopathy community.

8Dawn G. Foundation
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Listed as a member organization within the foundation alliance.

cfcsyndrome.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Federation of voluntary health organizations dedicated to rare diseases. CFC International is a member; NORD operates as a broad umbrella with policy, research, and patient support programs that span all rare conditions.

TypeBroad incumbent
Description

Public policy advocacy organization dedicated to accelerating biotech innovation for rare diseases. Operates across the rare disease ecosystem with policy and funding initiatives comparable to CFC International's advocacy focus but at much greater scale.

TypeRegional player
Description

European alliance of rare disease patient organizations. Comparable in mission to CFC International but operates regionally across Europe rather than as a single-condition US-based organization.

4Noonan Syndrome Foundation
TypeDirect peer
Description

Advocacy and research organization serving the Noonan syndrome community, another Ras/MAPK pathway disorder. Directly comparable in patient advocacy, family support, and research grantmaking mission.

TypeBroad incumbent
Description

World-leading nonprofit health advocacy network including over 1,200 disease-specific advocacy organizations. CFC International is a member; Genetic Alliance operates as a broad umbrella supporting genetic and rare disease communities.

TypeBroad incumbent
Description

Leading rare disease patient advocacy organization connecting over 500 global organizations under a unifying symbol of hope. CFC International is affiliated with Global Genes and shares its patient-advocacy mission across the broader rare disease landscape.

TypeDirect peer
Description

Patient advocacy and family support organization for Costello syndrome, a sibling condition to CFC within the Rasopathies family. Highly comparable non-profit advocacy model, family liaison approach, and research grant mission.

8NF Network
TypeDirect peer
Description

Patient advocacy organization for neurofibromatosis, a Rasopathy condition. Operates a closely analogous model of family support, regional chapters, and research funding, and is a Rasopathies Network collaborator of CFC International.

TypeDirect peer
Description

Leading research and advocacy organization for neurofibromatosis (NF1, NF2, schwannomatosis), which is part of the Rasopathies family. Listed as a CFC International partner and operates a comparable research grant and patient support model at larger scale.

TypeDirect peer
Description

Umbrella advocacy organization connecting syndromes sharing the Ras/MAPK pathway, including CFC, Costello, Noonan, and NF1. Direct strategic partner of CFC International with highly comparable mission, structure, and stakeholder community.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CFC International

Rare Disease Patient Advocacycfcsyndrome.org

CFC International is a U.S.-based nonprofit founded in 1999 that supports more than 1,200 families worldwide affected by Cardio-facio-cutaneous syndrome through advocacy, education, research grants, an AI-integrated patient registry, and a global volunteer liaison network.

What CFC International does

CFC International (legal name: Cardio Facio Cutaneous syndrome International) is a U.S.-based non-profit patient advocacy and research organization founded in 1999 and headquartered in Largo, Florida. It serves families and caregivers affected by Cardio-facio-cutaneous (CFC) syndrome — an ultra-rare genetic Ras/MAPK pathway disorder — connecting more than 1,200 families across North America, South America, Europe, Asia Pacific, the Middle East, and Asia. Its core programs include the Family Liaisons volunteer mentorship network, the Family Connect monthly newsletter, educational webinars, support groups, family medical conferences, patient emergency micro grants, and the annual Unstoppably Bold Day awareness event.

The organization's technology and research footprint centers on the CITIZEN Patient Registry, a centralized de-identified patient data platform built in partnership with CITIZEN Health that incorporates integrative AI tools to accelerate CFC syndrome research. It also operates the Lillian's Legacy Research Grant program — a named memorial fund that has disbursed over $250,000 in research funding, including a $50,000 award in 2025 to Brigham and Women's Hospital for seizure-mechanism research — and publishes a Research & Clinical Trials information hub, a Zotero-based research library, and an interactive CFC World Map showing the geographic distribution of registered families.

CFC International does not sell products or services. It is funded through donations, fundraising events (including an annual golf tournament and JustGiving-hosted peer-to-peer fundraisers), and grants, and it is governed by a volunteer Board of Directors led by CEO Tuesdi Dyer and President Alexis Nash. It maintains core memberships across the rare-disease advocacy ecosystem, including NORD, Global Genes, Genetic Alliance, the Rasopathies Network, and the Children's Tumor Foundation, and operates with a small staff of 1–10 employees supplemented by a country-level volunteer liaison network.

CFC International firmographics

Firmographics
Name
CFC International
Legal name
Cardio Facio Cutaneous syndrome International
Website
https://cfcsyndrome.org
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
11–50 employees
Short description
CFC International is a U.S.-based nonprofit founded in 1999 that supports more than 1,200 families worldwide affected by Cardio-facio-cutaneous syndrome through advocacy, education, research grants, an AI-integrated patient registry, and a global volunteer liaison network.
Ownership category
akta.pro rank

Where CFC International is headquartered

Location

Headquarters

HQ city
Largo
HQ country
United States
HQ region
North America

Offices1 record

Markets served

CFC International business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Distribution channels3 records

Marketing channels5 records

CFC International product offering

Product offering

Core offering

CFC International is a nonprofit patient advocacy organization that supports individuals and families affected by Cardio-facio-cutaneous (CFC) syndrome, a rare genetic disorder caused by mutations in MAPK pathway genes. The organization funds research, connects families, advocates for treatments, and operates the CITIZEN Patient Registry, a natural history study that uses AI to de-identify participant data for research use.

Product overview

CFC International operates as a non-profit patient advocacy and research organization — not a software technology company — offering a portfolio of patient-facing programs and research support services. The core offering is a coordinated set of support, education, and research-enabling programs including Family Liaisons (parent mentor connections), the CITIZEN Patient Registry (a centralized, AI-integrated de-identified data registry), Lillian's Legacy Research Grant (a named grant funding CFC syndrome research), Research & Clinical Trials information hub, and a global CFC World Map. These programs are supplemented by family medical conferences, webinars, support groups, patient emergency micro grants, and an annual awareness event (Unstoppably Bold Day). There is no commercial software product, platform, or API offering.

Differentiator

Problem solved

Functional benefit

Companies that use CFC International

Customer profile

Segments1 record

Ideal customer profiles2 records

CFC International technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

CFC International partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • National Organization for Rare Disorders (NORD)coreStrategic or Co-development PartnerCFC International is a proud member of NORD, a federation of voluntary health organizations dedicated to helping people with rare orphan diseases. This membership provides access to resources, advocacy support, and collaboration opportunities within the rare disease community.
  • Global GenescoreStrategic or Co-development PartnerCFC International is affiliated with Global Genes, a leading rare disease patient advocacy organization that connects over 500 global organizations under a unifying symbol of hope.
  • Genetic AlliancecoreStrategic or Co-development PartnerCFC International is a member of Genetic Alliance, a world-leading nonprofit health advocacy organization that engages individuals, families, and communities to transform health. The network includes over 1,200 disease-specific advocacy organizations.
  • Rasopathies NetworkcoreStrategic or Co-development PartnerCFC International collaborates with the Rasopathies Network, an organization connecting syndromes including CFC, Costello, Leopard/NSML, NF1, and Noonan that share the Ras/MAPK pathway. These syndromes affect approximately 1 in 1,000 individuals.
  • CITIZEN HealthcoreTechnology or IntegrationCFC International partnered with CITIZEN to develop a centralized patient registry with integrative AI tools that connects researchers, patients, and families to accelerate CFC syndrome research.
  • Brigham and Women's HospitalcoreStrategic or Co-development PartnerRecipient of CFC International's $50,000 Lillian's Legacy Research Grant for Dr. Sattar Khoshkhoo's research on seizures in CFC syndrome.
  • Children's Tumor FoundationminorStrategic or Co-development PartnerListed as a member organization, collaborating within the rare disease and Rasopathy community.
  • Dawn G. FoundationminorStrategic or Co-development PartnerListed as a member organization within the foundation alliance.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

CFC International competitors and assessment

Company assessment

Broad incumbents

  • National Organization for Rare Disorders (NORD): Federation of voluntary health organizations dedicated to rare diseases. CFC International is a member; NORD operates as a broad umbrella with policy, research, and patient support programs that span all rare conditions.
  • EveryLife Foundation for Rare Diseases: Public policy advocacy organization dedicated to accelerating biotech innovation for rare diseases. Operates across the rare disease ecosystem with policy and funding initiatives comparable to CFC International's advocacy focus but at much greater scale.
  • Genetic Alliance: World-leading nonprofit health advocacy network including over 1,200 disease-specific advocacy organizations. CFC International is a member; Genetic Alliance operates as a broad umbrella supporting genetic and rare disease communities.
  • Global Genes: Leading rare disease patient advocacy organization connecting over 500 global organizations under a unifying symbol of hope. CFC International is affiliated with Global Genes and shares its patient-advocacy mission across the broader rare disease landscape.

Regional players

  • EURORDIS - Rare Diseases Europe: European alliance of rare disease patient organizations. Comparable in mission to CFC International but operates regionally across Europe rather than as a single-condition US-based organization.

Direct peers

  • Noonan Syndrome Foundation: Advocacy and research organization serving the Noonan syndrome community, another Ras/MAPK pathway disorder. Directly comparable in patient advocacy, family support, and research grantmaking mission.
  • Costello Syndrome Family Network: Patient advocacy and family support organization for Costello syndrome, a sibling condition to CFC within the Rasopathies family. Highly comparable non-profit advocacy model, family liaison approach, and research grant mission.
  • NF Network: Patient advocacy organization for neurofibromatosis, a Rasopathy condition. Operates a closely analogous model of family support, regional chapters, and research funding, and is a Rasopathies Network collaborator of CFC International.
  • Children's Tumor Foundation: Leading research and advocacy organization for neurofibromatosis (NF1, NF2, schwannomatosis), which is part of the Rasopathies family. Listed as a CFC International partner and operates a comparable research grant and patient support model at larger scale.
  • Rasopathies Network: Umbrella advocacy organization connecting syndromes sharing the Ras/MAPK pathway, including CFC, Costello, Noonan, and NF1. Direct strategic partner of CFC International with highly comparable mission, structure, and stakeholder community.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

CFC International social profiles

Digital presence

CFC International financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CFC International leadership team

Management profile

Number of profiles

CFC International funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CFC International M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CFC International

What does CFC International do?

CFC International is a nonprofit patient advocacy organization that supports individuals and families affected by Cardio-facio-cutaneous (CFC) syndrome, a rare genetic disorder caused by mutations in MAPK pathway genes. The organization funds research, connects families, advocates for treatments, and operates the CITIZEN Patient Registry, a natural history study that uses AI to de-identify participant data for research use.

Is CFC International a public or private company?

CFC International is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was CFC International founded?

CFC International was founded in 1999. It employs 11 to 50 people.

Where is CFC International based?

CFC International is headquartered in Largo, United States, in the North America region.

Who are CFC International's main competitors?

Broad incumbents on record are National Organization for Rare Disorders (NORD), EveryLife Foundation for Rare Diseases, Genetic Alliance and Global Genes. EURORDIS - Rare Diseases Europe is listed as a regional player. Direct peers are Noonan Syndrome Foundation, Costello Syndrome Family Network, NF Network, Children's Tumor Foundation and Rasopathies Network.

Does CFC International have an API?

No public API is recorded for CFC International.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales